1. Home
  2. Labeler Index
  3. Indivior Inc.
  4. NDC Product Code: 12496-0120 Perseris

NDC 12496-0120 Perseris

Risperidone Kit Subcutaneous - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 12496-0120?
  4. Perseris Uses
  5. Active Ingredients UNII Codes
  6. Inactive Ingredients UNII Codes
  7. NDC to RxNorm Crosswalk
  8. Patient Education

Product Information

NDC Product Code:
12496-0120
Proprietary Name:
Perseris
Non-Proprietary Name: [1]
Risperidone
NDC Directory Status:
Human Prescription Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Kit - A packaged collection of related material.
Administration Route(s): [4]
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Labeler Name: [5]
    Indivior Inc.
    Labeler Code:
    12496
    Product Label ID:
    a4f21b1a-5691-4b14-a56d-651962d06f39
    FDA Application Number: [6]
    NDA210655
    Marketing Category: [8]
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date: [9]
    11-09-2018
    Listing Expiration Date: [11]
    12-31-2024
    Exclude Flag: [12]
    N
    Code Structure:
    Code Navigator:

    Product Packages

    NDC Code 12496-0120-1

    Package Description: 1 KIT in 1 CARTON * 1 SYRINGE in 1 POUCH (12496-0120-2) / 1.2 mL in 1 SYRINGE (12496-0120-5) * 1 SYRINGE in 1 POUCH (12496-0776-2) / 1 mL in 1 SYRINGE (12496-0776-5)

    Price per Unit: $2771.29020 per EA

    NDC Code 12496-0120-9

    Package Description: 1 KIT in 1 CARTON * 1 SYRINGE in 1 POUCH (12496-0120-2) / 1.2 mL in 1 SYRINGE (12496-0120-5) * 1 SYRINGE in 1 POUCH (12496-0776-2) / 1 mL in 1 SYRINGE (12496-0776-5)

    Product Details

    What is NDC 12496-0120?

    The NDC code 12496-0120 is assigned by the FDA to the product Perseris which is a human prescription drug product labeled by Indivior Inc.. The generic name of Perseris is risperidone. The product's dosage form is kit and is administered via subcutaneous form. The product is distributed in 2 packages with assigned NDC codes 12496-0120-1 1 kit in 1 carton * 1 syringe in 1 pouch (12496-0120-2) / 1.2 ml in 1 syringe (12496-0120-5) * 1 syringe in 1 pouch (12496-0776-2) / 1 ml in 1 syringe (12496-0776-5), 12496-0120-9 1 kit in 1 carton * 1 syringe in 1 pouch (12496-0120-2) / 1.2 ml in 1 syringe (12496-0120-5) * 1 syringe in 1 pouch (12496-0776-2) / 1 ml in 1 syringe (12496-0776-5). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Perseris?

    Risperidone is used to treat a certain mental/mood disorder called schizophrenia. This medication can decrease hallucinations, help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Risperidone is an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural substances in the brain.

    Which are Perseris UNII Codes?

    The UNII codes for the active ingredients in this product are:

    Which are Perseris Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    • POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 46000 MW) (UNII: LQ35R50VR1)
    • METHYLPYRROLIDONE (UNII: JR9CE63FPM)

    What is the NDC to RxNorm Crosswalk for Perseris?

    RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

    * Please review the disclaimer below.

    Patient Education

    Risperidone Injection


    Risperidone extended-release (long-acting) injection is used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Risperidone extended-release injection is used alone or in combination with lithium (Lithobid) or valproate (Depacon) to treat people who have bipolar I disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of severe mania, and other abnormal moods). Risperidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
    [Learn More]


    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".